FCGR1A and neoplasm: Co-administration of CD64 IR T cells slowed the growth of the Jurkat cells compared to that seen in the control mice; however, addition of Vβ8 antibody was seen to augment the response to CD64 IR T cells and significantly inhibit tumor growth compared to the Jurkat cell only control group (Figure 3A, p = 0.0079).